Literature DB >> 22713125

A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy.

Elena S Mazzone1, Gessica Vasco, Concetta Palermo, Flaviana Bianco, Carmen Galluccio, Valeria Ricotti, Antonella D Castronovo, Maria Sole D I Mauro, Marika Pane, Anna Mayhew, Eugenio Mercuri.   

Abstract

The recent development of therapeutic approaches for Duchenne muscular dystrophy (DMD) has highlighted the need to identify clinical outcome measures for planned efficacy studies. Although several studies have reported the value of functional scales, timed tests, and measures of endurance aimed at ambulant individuals, less has been done to identify reliable measures of function in individuals who have lost ambulation. The aim of this paper is to provide a critical review of the existing literature on functional measures assessing upper extremity function in DMD. Four observer-rated, performance-based measures and four self-reported scales have been previously used in DMD. Each scale provides useful information but none reflects all the different levels of functional ability in activities of daily living observed in individuals with DMD at different ages. © The Authors. Developmental Medicine & Child Neurology
© 2012 Mac Keith Press.

Entities:  

Mesh:

Year:  2012        PMID: 22713125     DOI: 10.1111/j.1469-8749.2012.04345.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  26 in total

1.  Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy.

Authors:  Roxanna M Bendixen; Jocelyn Butrum; Mina S Jain; Rebecca Parks; Bonnie Hodsdon; Carmel Nichols; Michelle Hsia; Leslie Nelson; Katherine C Keller; Michelle McGuire; Jeffrey S Elliott; Melody M Linton; Irene C Arveson; Fatou Tounkara; Ruhi Vasavada; Elizabeth Harnett; Monal Punjabi; Sandra Donkervoort; Jahannaz Dastgir; Meganne E Leach; Anne Rutkowski; Melissa Waite; James Collins; Carsten G Bönnemann; Katherine G Meilleur
Journal:  Neuromuscul Disord       Date:  2016-12-05       Impact factor: 4.296

2.  Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases.

Authors:  Jay J Han; Gregorij Kurillo; R Ted Abresch; Alina Nicorici; Ruzena Bajcsy
Journal:  PLoS Curr       Date:  2013-12-12

3.  Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle.

Authors:  Jia Li; Tom R Geisbush; Glenn D Rosen; Jennifer Lachey; Aaron Mulivor; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

Review 4.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

5.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

6.  Upper extremity 3-dimensional reachable workspace analysis in dystrophinopathy using Kinect.

Authors:  Jay J Han; Gregorij Kurillo; Richard T Abresch; Evan De Bie; Alina Nicorici; Ruzena Bajcsy
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

Review 7.  Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.

Authors:  Alessandra Govoni; Francesca Magri; Simona Brajkovic; Chiara Zanetta; Irene Faravelli; Stefania Corti; Nereo Bresolin; Giacomo P Comi
Journal:  Cell Mol Life Sci       Date:  2013-06-18       Impact factor: 9.261

8.  Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy.

Authors:  Anne M Connolly; Elizabeth C Malkus; Jerry R Mendell; Kevin M Flanigan; J Philip Miller; Jeanine R Schierbecker; Catherine A Siener; Paul T Golumbek; Craig M Zaidman; Craig M Mcdonald; Linda Johnson; Alina Nicorici; Peter I Karachunski; John W Day; Jason M Kelecic; Linda P Lowes; Lindsay N Alfano; Basil T Darras; Peter B Kang; Janet Quigley; Amy E Pasternak; Julaine M Florence
Journal:  Muscle Nerve       Date:  2015-02-11       Impact factor: 3.217

9.  Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy.

Authors:  Melissa A Goddard; David L Mack; Stefan M Czerniecki; Valerie E Kelly; Jessica M Snyder; Robert W Grange; Michael W Lawlor; Barbara K Smith; Alan H Beggs; Martin K Childers
Journal:  Ann Transl Med       Date:  2015-10

10.  Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy.

Authors:  Jay J Han; Evan de Bie; Alina Nicorici; Richard T Abresch; Colleen Anthonisen; Ruzena Bajcsy; Gregorij Kurillo; Craig M Mcdonald
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.